Biblio

Export 215 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
P. D. Mehta, Blain, J. - F., Freeman, E. A., Patrick, B. A., Barshatzky, M., Hrdlicka, L. A., Mehta, S. P., Frackowiak, J., Mazur-Kolecka, B., Wegiel, J., Patzke, H., and Miller, D. L., “Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1-37 (Aβ37).”, J Alzheimers Dis, vol. 57, no. 1, pp. 135-145, 2017.
P. D. Mehta, Patrick, B. A., Barshatzky, M., Mehta, S. P., Frackowiak, J., Mazur-Kolecka, B., Wegiel, J., Wisniewski, T., and Miller, D. L., “Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ).”, J Alzheimers Dis, vol. 62, no. 4, pp. 1635-1649, 2018.
H. B. Mehta, Mehta, V., Tsai, C. - L., Chen, H., Aparasu, R. R., and Johnson, M. L., “Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.”, J Alzheimers Dis, vol. 49, no. 2, pp. 423-32, 2016.
W. E Mehling, M Scott, T., Duffy, J., A Whitmer, R., A Chesney, M., W Boscardin, J., and E Barnes, D., “Dyadic Group Exercises for Persons with Memory Deficits and Care Partners: Mixed-Method Findings from the Paired Preventing Loss of Independence through Exercise (PLIÉ) Randomized Trial.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1689-1706, 2020.
J. Mehla, Lacoursiere, S., Stuart, E., McDonald, R. J., and Mohajerani, M. H., “Gradual Cerebral Hypoperfusion Impairs Fear Conditioning and Object Recognition Learning and Memory in Mice: Potential Roles of Neurodegeneration and Cholinergic Dysfunction.”, J Alzheimers Dis, vol. 61, no. 1, pp. 283-293, 2018.
R. H. Mehder, Bennett, B. M., and R Andrew, D., “Morphometric Analysis of Hippocampal and Neocortical Pyramidal Neurons in a Mouse Model of Late Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1069-1083, 2020.
K. Meguro and Dodge, H. H., “Vascular Mild Cognitive Impairment: Identifying Disease in Community-Dwelling Older Adults, Reducing Risk Factors, and Providing Support. The Osaki-Tajiri and Kurihara Projects.”, J Alzheimers Dis, vol. 70, no. s1, pp. S293-S302, 2019.
A. E. Medvedev, Radko, S. P., Yurinskaya, M. M., Vinokurov, M. G., Buneeva, O. A., Kopylov, A. T., Kozin, S. A., Mitkevich, V. A., and Makarov, A. A., “Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.”, J Alzheimers Dis, vol. 66, no. 1, pp. 263-270, 2018.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., “Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.”, J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
P. Mecocci, Boccardi, V., Cecchetti, R., Bastiani, P., Scamosci, M., Ruggiero, C., and Baroni, M., “A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1319-1335, 2018.
P. Mecocci, Baroni, M., Senin, U., and Boccardi, V., “Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?”, J Alzheimers Dis, vol. 64, no. s1, pp. S397-S404, 2018.
E. Mead, Kestoras, D., Gibson, Y., Hamilton, L., Goodson, R., Jones, S., Eversden, S., Davies, P., O'Neill, M., Hutton, M., Szekeres, P., and Wolak, J., “Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1521-1538, 2016.
K. E. McLimans and Willette, A. A., “Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.”, J Alzheimers Dis, vol. 56, no. 1, pp. 403-413, 2017.
K. E. McLimans, Webb, J. L., Anantharam, V., Kanthasamy, A., and Willette, A. A., “Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1313-1324, 2017.
A. C. McKinnon, Duffy, S. L., Cross, N. E., Terpening, Z., Grunstein, R. R., Lagopoulos, J., Batchelor, J., Hickie, I. B., Lewis, S. J. G., Shine, J. M., and Naismith, S. L., “Functional Connectivity in the Default Mode Network is Reduced in Association with Nocturnal Awakening in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1373-1384, 2017.
G. M. McKhann, Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H., “The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.”, Alzheimers Dement, vol. 7, no. 3, pp. 263-9, 2011.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., “Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
E. R. McGrath, Himali, J. J., Levy, D., Yang, Q., DeCarli, C. S., Courchesne, P., Satizabal, C. L., Finney, R., Vasan, R. S., Beiser, A. S., and Seshadri, S., “Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1657-1666, 2021.
R. McGrath, Robinson-Lane, S. G., Klawitter, L., Rhee, Y., Hamm, J. M., McCourt, M. E., Parker, K., and Hackney, K. J., “Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults.”, J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
E. G. McGeer and McGeer, P. L., “Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy.”, J Alzheimers Dis, vol. 19, no. 1, pp. 355-61, 2010.
P. L. McGeer, Guo, J. Ping, Lee, M., Kennedy, K., and McGeer, E. G., “Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1219-1222, 2018.
P. L. McGeer, Rogers, J., and McGeer, E. G., “Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.”, J Alzheimers Dis, vol. 54, no. 3, pp. 853-857, 2016.
P. G McFall, McDermott, K. L., and Dixon, R. A., “Modifiable Risk Factors Discriminate Memory Trajectories in Non-Demented Aging: Precision Factors and Targets for Promoting Healthier Brain Aging and Preventing Dementia.”, J Alzheimers Dis, vol. 70, no. s1, pp. S101-S118, 2019.
S. C. McEwen, Siddarth, P., Abedelsater, B., Kim, Y., Mui, W., Wu, P., Emerson, N. D., Lee, J., Greenberg, S., Shelton, T., Kaiser, S., Small, G. W., and Merrill, D. A., “Simultaneous Aerobic Exercise and Memory Training Program in Older Adults with Subjective Memory Impairments.”, J Alzheimers Dis, vol. 62, no. 2, pp. 795-806, 2018.
B. McDermott, Porter, E., Hughes, D., McGinley, B., Lang, M., O'Halloran, M., and Jones, M., “Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 2, pp. 363-392, 2018.

Pages